Getting pregnant after Mounjaro: what the guidance actually says

You've finished Mounjaro and now want to try for a baby, here's the situation

You've stopped treatment, lost meaningful weight, and pregnancy is now the goal. That is a common and entirely understandable path. Mounjaro does not cause permanent infertility, and stopping treatment does not leave a lasting barrier to conception. What matters is allowing enough time between your last injection and trying to conceive.

Tirzepatide has a half-life of roughly five days, but clinical guidance from NHS England and the prescribing information recommend allowing a proper wash-out period rather than trying the week after your last pen. Your prescriber will give you the specific timeframe that applies to your circumstances. If you were on a higher maintenance dose, that conversation is especially worth having before anything else.

One practical note: if you are also managing other aspects of your health alongside this decision, timing matters more than it might seem. People sometimes plan these transitions around payday, a holiday or the start of a new month. That is fine, but the wash-out window should drive the timing, not the calendar. Speak to your GP or the prescriber who managed your treatment before you stop, not after.

The full Mounjaro overview on our site covers how the medicine works if you need a refresher on the basics before that conversation.

What weight loss itself does to fertility, the less-discussed part

Here is something that often surprises people: significant weight loss can increase fertility before you have even stopped treatment. For women with obesity-related hormonal disruption, including polycystic ovary syndrome (PCOS), losing body weight can restore more regular ovulation. That is a benefit, but it is also a reason why reliable contraception throughout Mounjaro treatment is critical if pregnancy is not yet the intention.

The NHS guidance on weight-management injections is explicit on this point: do not assume weight loss reduces your chance of conceiving, because the opposite can be true. There is a separate, important issue specific to tirzepatide: because Mounjaro slows gastric emptying, oral contraceptive pills may be absorbed less consistently during the first four weeks of treatment and for four weeks after each dose increase. The practical advice from NHS England's weight-management guidance is to add a non-oral method such as condoms during those windows.

If you want to read more about the contraception picture during active treatment, the page on getting pregnant while on Mounjaro covers that in detail. For questions that arise once treatment has already stopped and a pregnancy is confirmed, this page on Mounjaro and pregnancy is the more relevant starting point.

What we know, what is still uncertain, and who should decide

The honest clinical picture is this: the available safety data on tirzepatide in human pregnancy is limited. Most of what exists comes from animal studies, which showed developmental effects at doses relevant to human use. That is why the medicine's prescribing information and UK regulatory guidance both state clearly that Mounjaro should not be used during pregnancy, and that women should stop treatment before trying to conceive.

What is less settled is the precise length of the wash-out period that should be observed. The Mounjaro Summary of Product Characteristics on the eMC gives the licensed guidance on this, and your prescriber or GP is the right person to translate that into a personal plan. This is not a situation where a general estimate from the internet is a safe substitute for an individual clinical conversation, particularly if you have other conditions that were part of the reason for treatment.

The MHRA has separately flagged that women of childbearing age on GLP-1 medicines should receive clear contraception advice throughout, and that planning conception means involving their healthcare team in the stop decision. If you are thinking about returning to Mounjaro after a pregnancy, the page on restarting Mounjaro after pregnancy is worth reading once you are through that chapter. And if you would like to understand how tirzepatide can affect kidney function, including what to watch for, before making any decisions, the NHS tirzepatide page is a reliable starting point.

If you are at the stage of thinking about what comes next for your weight management after this period, our consultation page is there when the time is right. Those who are weighing up whether Mounjaro affects the chances of getting pregnant will find that question addressed in full on its own dedicated page.